24 HR Levetiracetam 750 MG Extended Release Oral Tablet
1 INDICATIONS & USAGE Levetiracetam extended-release tablets is indicated as adjunctive therapy in the treatment of partial onset seizures in patients > 16 years of age with epilepsy.
Par Pharmaceutical
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED Levetiracetam extended-release tablets 750 mg are white, oblong-shaped, film coated tablets imprinted with “BOCA 697” in green on one side. They are supplied in white HDPE bottles containing 300 tablets (NDC 64376-697-32), and in bottles containing 60 tablets (64376-697-61).
More pills like OVAL BOCA 697